Daniel J. Leahy
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Daniel J. Leahy has a total of 62 co-authors. Here are the top co-authors by number of shared publications:
Jennifer M. Kavran
Johns Hopkins School of Medicine, Baltimore, MD 21209, USA
9 shared publicationsPatti A. Longo
Johns Hopkins University School of Medicine, Baltimore, MD, USA
6 shared publicationsMin-Sung Kim
Johns Hopkins University School of Medicine, Baltimore, MD, USA
4 shared publicationsSamuel Bouyain
Department of Biophysics and Biophysical Chemistry, Johns Hopkins University School of Medicine, 725 N. Wolfe Street, Baltimore, MD 21205
4 shared publicationsPhilip A. Beachy
Department of Developmental Biology, Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, California 94305, USA
3 shared publicationsBrent Y. Hamaoka
Department of Biophysics and Biophysical Chemistry, Johns Hopkins University School of Medicine, Baltimore, MD 21205; and
2 shared publications
Latest Publications
- Open Access
- 1 February 2015
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 290 (6) , 3500-3507
Smoothened Goes Molecular: New Pieces in the Hedgehog Signaling Puzzle
- 1 February 2015
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 290 (6) , 3500-3507
Open AccessSmoothened Goes Molecular: New Pieces in the Hedgehog Signaling Puzzle
- 1 January 2015
- Published by Elsevier in Biophysical Journal
- Vol. 108 (2) , 372a-373a
Using Biochemical and Structural Approaches to Study ErbB2-Containing Heterodimers
- 1 January 2015
- Published by Elsevier in Biophysical Journal
- Vol. 108 (2) , 372a-373a
Using Biochemical and Structural Approaches to Study ErbB2-Containing Heterodimers
- Open Access
- 1 January 2015
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 290 (3) , 1570-1579
Kinase Activator-Receiver Preference in ErbB Heterodimers Is Determined by Intracellular Regions and Is Not Coupled to Extracellular Asymmetry
- 1 January 2015
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 290 (3) , 1570-1579
Open AccessKinase Activator-Receiver Preference in ErbB Heterodimers Is Determined by Intracellular Regions and Is Not Coupled to Extracellular Asymmetry
- 1 December 2014
- Published by Elsevier in Protein Expression and Purification
- Vol. 104, 92-102
Detergent-solubilized Patched purified from Sf9 cells fails to interact strongly with cognate Hedgehog or Ihog homologs
- 1 December 2014
- Published by Elsevier in Protein Expression and Purification
- Vol. 104, 92-102
Detergent-solubilized Patched purified from Sf9 cells fails to interact strongly with cognate Hedgehog or Ihog homologs
- Open Access
- 25 September 2014
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 3
How IGF-1 activates its receptor
The type I insulin-like growth factor receptor (IGF1R) is involved in growth and survival of normal and neoplastic cells. A ligand-dependent conformational change is thought to regulate IGF1R activity, but the nature of this change is unclear. We point out an underappreciated dimer in the crystal structure of the related Insulin Receptor (IR) with Insulin bound that allows direct comparison with unliganded IR and suggests a mechanism by which ligand regulates IR/IGF1R activity. We test this mechanism in a series of biochemical and biophysical assays and find the IGF1R ectodomain maintains an autoinhibited state in which the TMs are held apart. Ligand binding releases this constraint, allowing TM association and unleashing an intrinsic propensity of the intracellular regions to autophosphorylate. Enzymatic studies of full-length and kinase-containing fragments show phosphorylated IGF1R is fully active independent of ligand and the extracellular-TM regions. The key step triggered by ligand binding is thus autophosphorylation.
- 25 September 2014
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 3
Open AccessHow IGF-1 activates its receptor
The type I insulin-like growth factor receptor (IGF1R) is involved in growth and survival of normal and neoplastic cells. A ligand-dependent conformational change is thought to regulate IGF1R activity, but the nature of this change is unclear. We point out an underappreciated dimer in the crystal structure of the related Insulin Receptor (IR) with Insulin bound that allows direct comparison with unliganded IR and suggests a mechanism by which ligand regulates IR/IGF1R activity. We test this mechanism in a series of biochemical and biophysical assays and find the IGF1R ectodomain maintains an autoinhibited state in which the TMs are held apart. Ligand binding releases this constraint, allowing TM association and unleashing an intrinsic propensity of the intracellular regions to autophosphorylate. Enzymatic studies of full-length and kinase-containing fragments show phosphorylated IGF1R is fully active independent of ligand and the extracellular-TM regions. The key step triggered by ligand binding is thus autophosphorylation.
- 1 January 2014
- Published by Elsevier
- Vol. 541, 27-34
Coupling Antibody to Cyanogen Bromide-Activated Sepharose
- 1 January 2014
- Published by Elsevier
- Vol. 541, 27-34
Coupling Antibody to Cyanogen Bromide-Activated Sepharose
- 1 January 2014
- Published by Elsevier
- Vol. 536, 165-172
Single Cell Cloning of a Stable Mammalian Cell Line
- 1 January 2014
- Published by Elsevier
- Vol. 536, 165-172
Single Cell Cloning of a Stable Mammalian Cell Line